Making the case: Eclypse® Superabsorbent Dressings

Share this article

Making the case: Eclypse® Superabsorbent Dressings

Supported by Advancis Medical
26 February 2021

Managing exudate still presents a key challenge in clinical practice. Unmanaged exudate can delay healing, increase the risk of wound complications, and damage the surrounding skin. This can have a significant impact on healing time, cost and patients’ quality of life (WUWHS, 2019), with some patients reporting odour and exudate as the most disturbing consequences of having a chronic wound (Jones, 2008). The prevalence of exudate-related damage is not well documented, but it is acknowledged that its impact is ‘substantial’, both on individuals and healthcare systems (Woo et al, 2017). One largescale international survey involving 2,018 patients with chronic wounds found that 25% of respondents experienced pain around the wound, likely from periwound maceration and local inflammatory responses (Price et al, 2008). Periwound maceration from unmanaged exudate delays overall wound healing, and is also correlated with higher pain levels prior to and during dressing changes (Woo et al, 2017).

Supported by Advancis Medical

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.